Covered Stent Market Size worth $1,687.25 Million by 2032 | CAGR: 4.25%

The global Covered Stent Market is expected to grow at growth rate of 4.25% to reach USD 1,687.29 Million by 2032.

A covered stent is a specialized medical stent designed with a synthetic or biological membrane covering its surface. This protective layer enhances the stent’s functionality and durability, offering significant advantages over bare-metal stents. Covered stents are widely utilized in vascular and non-vascular procedures to effectively treat various medical conditions.

The covered stent market is experiencing substantial growth, driven by the increasing prevalence of cardiovascular and vascular diseases, continuous advancements in stent technology, and a rising aging population. Conditions such as aortic aneurysms and peripheral artery disease (PAD) are becoming more common due to factors like unhealthy lifestyles, smoking, and high cholesterol levels. Covered stents provide a minimally invasive solution for blood vessel repair, making them an increasingly preferred option for treating vascular complications. Additionally, the growing incidence of hypertension and diabetes further contributes to the demand for advanced vascular treatment options like covered stents.

Request Sample Copy of Report: Covered Stent Market

Recent innovations in stent materials and design have significantly improved flexibility, durability, and biocompatibility. Modern covered stents, made from materials such as polytetrafluoroethylene (PTFE) and nitinol, offer enhanced structural integrity and seamless adaptability to the vascular system. These stents provide minimally invasive treatment alternatives, reducing surgical risks and recovery times compared to traditional open surgeries. Covered stents are also highly effective in managing vascular trauma caused by accidents and industrial injuries, further driving market demand for fast and reliable vascular repair solutions. Moreover, advancements in fenestrated and branched stent-grafts have expanded treatment options for complex vascular conditions, such as thoracoabdominal aneurysms, reinforcing the growing adoption of covered stent technology worldwide.

The covered stent market is geographically widespread across North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. North America holds the largest market share, driven by its advanced healthcare infrastructure, high adoption of new medical technologies, and the strong presence of leading manufacturers. Europe also commands a significant share due to rising healthcare investments and advancements in vascular disease management. The Asia Pacific region is experiencing rapid growth, fueled by improvements in healthcare infrastructure, increasing awareness, and a rising burden of vascular diseases. China and India are key contributors to this growth, supported by their large populations and expanding access to healthcare services. The global covered stent market was valued at USD 1.13 billion in 2023 and is projected to grow at a CAGR of 4.1% from 2024 to 2030.

KEY BENEFITS OF THE REPORT:

• Insights into strategies adopted by key players to maintain competitiveness.
• Comprehensive analysis of the leading companies shaping the competitive landscape.
• Examination of the key drivers fuelling global market growth.
• Identification of the geographic regions expected to experience the highest growth.
• Detailed evaluation of the current market conditions and future growth projections.

The global covered stent market is experiencing steady growth, driven by the increasing prevalence of vascular diseases and continuous advancements in medical technology. Leading companies are making significant investments in research and development to introduce innovative products and expand their market reach. Manufacturers are focusing on developing stents with enhanced flexibility, deliverability, and anatomical compatibility to address complex vascular conditions.

Recent advancements include the development of thinner profiles and improved flexibility, particularly for percutaneous coronary interventions (PCI) and other intricate procedures. Regulatory approvals remain crucial for market expansion, with companies actively seeking certifications from bodies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to launch their products in new markets. In april 2024: Getinge entered a commercial distribution agreement with Cook Medical to introduce the iCast Covered Stent System to the U.S. market.

The scope of this report covers the market by its major segments, which include as follows:

Market Segmentation

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL COVERED STENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Ø Boston Scientific Corporation

Ø Medtronic

Ø W. L. Gore & Associates, Inc.

Ø Cook Medical

Ø Terumo Corporation

Ø B. Braun Interventional Systems, Inc.

Ø BD

Ø Getinge

Ø Biotronik

Ø Abbott Laboratories

Ø Cardinal Health

Ø Merit Medical Systems

Ø Endologix LLC

Ø MicroPort Scientific Corporation

Ø Lombard Medical

Ø Others

GLOBAL COVERED STENT MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032

Ø Vascular Stent

Ø Non-vascular Stent

GLOBAL COVERED STENT MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

Ø Aortic aneurysms

Ø Biliary stenting

Ø Esophageal and Gastrointestinal

GLOBAL COVERED STENT MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

Ø Hospitals

Ø Specialty Clinics

Ø Ambulatory Care Centers

GLOBAL COVERED STENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America

U.S.

Canada

Europe

Germany

Uk

France

Italy

Spain

The Netherlands

Sweden

Russia

Poland

Rest Of Europe

Asia Pacific

China

India

Japan

South Korea

Australia

Indonesia

Thailand

Philippines

Rest Of Apac

Latin America

Brazil

Mexico

Argentina

Colombia

Rest Of Latam

The Middle East And Africa

Saudi Arabia

Uae

Israel

Turkey

Algeria

Egypt

Rest Of Mea

o Algeria

o Egypt

o Rest of MEA